Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
出版年份 2020 全文链接
标题
Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
作者
关键词
-
出版物
Stem Cells International
Volume 2020, Issue -, Pages 1-10
出版商
Hindawi Limited
发表日期
2020-02-04
DOI
10.1155/2020/6574010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway
- (2019) Xiaoli Rong et al. Stem Cell Research & Therapy
- Approaches and Methods to Measure Oxidative Stress in Clinical Samples: Research Applications in the Cancer Field
- (2019) Meghri Katerji et al. Oxidative Medicine and Cellular Longevity
- Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy
- (2019) Tariq Hussain et al. Cells
- Mesenchymal stem cells and their conditioned medium can enhance the repair of uterine defects in a rat model
- (2018) Chi-Hong Ho et al. Journal of the Chinese Medical Association
- The Effects of Conditioned Medium Derived from Mesenchymal Stem Cells Cocultured with Hepatocytes on Damaged Hepatocytes and Acute Liver Failure in Rats
- (2018) Li Chen et al. Stem Cells International
- Simple spectrophotometric assay for measuring catalase activity in biological tissues
- (2018) Mahmoud Hussein Hadwan BMC BIOCHEMISTRY
- Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice
- (2018) Yusuke Watanabe et al. Stem Cells Translational Medicine
- Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis
- (2016) Shu Dong et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Stem Cell-Derived Exosomes: A Potential Alternative Therapeutic Agent in Orthopaedics
- (2016) John Burke et al. Stem Cells International
- New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials
- (2016) Kai Qu et al. Frontiers in Pharmacology
- Effective Prevention of Liver Fibrosis by Liver-targeted Hydrodynamic Gene Delivery of Matrix Metalloproteinase-13 in a Rat Liver Fibrosis Model
- (2016) Hiroyuki Abe et al. Molecular Therapy-Nucleic Acids
- Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: An insight
- (2014) Gamal E Shiha et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- The Effect of Conditioned Media of Adipose-Derived Stem Cells on Wound Healing after Ablative Fractional Carbon Dioxide Laser Resurfacing
- (2013) Bing-Rong Zhou et al. Biomed Research International
- Clinical evidence for the regression of liver fibrosis
- (2012) Elizabeth L. Ellis et al. JOURNAL OF HEPATOLOGY
- Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression
- (2011) Mohamed E. Shaker et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib
- (2011) Yuqing Liu et al. JOURNAL OF HEPATOLOGY
- Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis
- (2011) Mohamed E. Shaker et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started